RBC Capital offerd its weekly prescription tracker for Valeant Pharma (NYSE: VRX) today. The firm rates Valeant at Sector ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE